Michael D Deel
Assistant Professor of Pediatrics
Dr. Deel is a clinician scientist in Pediatric Hematology/Oncology. In addition to caring for pediatric patients with hematologic disorders or malignancy, his research focuses on finding novel ways to target fusion-positive pediatric sarcomas. His current work focuses on understanding the gene regulation and molecular pathways responsible for alveolar rhabdomyosarcoma, which is among the most difficult to cure pediatric cancers. Alveolar rhabdomyosarcoma is driven by chromosomal translocations t(2;13) or t(1;13) that result in oncogenic transcription factors encoding for PAX3/7-FOXO1 fusion proteins. The PAX3/7-FOXO1 oncogenes are currently not viable therapeutic targets. Using a variety of cell culture and murine models, Dr. Deel is investigating genes and pathways that regulate or coordinate PAX3/7-FOXO1-mediated tumorigenesis.
Current Appointments & Affiliations
- Assistant Professor of Pediatrics, Pediatrics, Hematology-Oncology, Pediatrics 2021
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2018
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2018
Contact Information
- Duke University Medical Center, Box 102382, Durham, NC 27710
- Duke University, Box 102382, Durham, NC 27710
-
michael.deel@duke.edu
(919) 681-6173
-
The Deel Lab
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.